Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.

Journal of Parkinson's disease - 1 Jan 2021

Bougea Anastasia, Koros Christos, Papagiannakis Nikolaos, Simitsi Athina-Maria, Prentakis Andreas, Papadimitriou Dimitra, Pachi Ioanna, Antonelou Roubina, Angelopoulou Efthalia, Beratis Ion, Bozi Maria, Papageorgiou Sokratis G, Trapali Xenia Geronicola, Stamelou Maria, Stefanis Leonidas

Abstract excerpt

BACKGROUND: Previous studies have highlighted serum uric acid as a putative idiopathic Parkinson's disease (iPD) biomarker. Only one study, so far, showed higher levels of serum uric acid in leucine-rich repeat kinase 2 (LRRK + 2) carriers compared to those who developed PD, however a longitudinal comparison between LRRK2 + PD and healthy controls (HC) has not been performed. OBJECTIVE: The aim of this study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation

Share to Parkinson Disease

Share to Uric Acid

Source

Identifiers

PMID: 33682725
DOI: 10.3233/JPD-202337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.PMID 33682725Read ↗

Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson’s disease: Longitudinal data from the PPMI studySemantic proximity Read ↗

Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study.Semantic proximity Read ↗

Severe and regionally-widespread increases in tissue urea in the human brain represent a novel finding of pathogenic potential in Parkinson’s disease dementiaSemantic proximity Read ↗

Serum uric acid and risk of dementia in Parkinson's diseaseSemantic proximity Read ↗

Metabolomic profiling in LRRK2-related Parkinson's disease.Semantic proximity Read ↗

Urate in Parkinson’s Disease: More Than a Biomarker?Semantic proximity Read ↗

Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.Semantic proximity Read ↗

Disease progression in LRRK2 parkinsonism.Semantic proximity Read ↗

Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseSemantic proximity Read ↗

Biomarkers of Parkinson's Disease: Screening Vital Signs and Routine Blood TestsSemantic proximity Read ↗

Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.Semantic proximity Read ↗

Uric Acid and Purine Recycling Disorders in Parkinson’s Disease: A Cross-Sectional StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.